|Bid||3.74 x 1100|
|Ask||9.47 x 1100|
|Day's Range||8.92 - 9.52|
|52 Week Range||7.80 - 23.21|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||0.11|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK & LONDON & HONG KONG, May 25, 2022--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, released more than 100 enhancements and new features for its Order and Execution Management System (OEMS) in Q1 2022, as the asset management community increasingly shifts towards solutions that address the complexities associated with managing sophisticated daily order flow.
NEW YORK & LONDON & HONG KONG, May 12, 2022--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced financial results for the first quarter ended March 31, 2022.
CHICAGO, May 10, 2022--As part of its continuing strategy to serve client needs across the entire investment lifecycle, Northern Trust (Nasdaq: NTRS) has established a relationship with Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native investment management software and services, to provide portfolio management, order and execution management system (OEMS), and analytics capabilities to mutual clients.